Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • KING PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 947.16 M 1.37 B 1.00 B 655.08 M 456.31 M
    Net Receivables 245.07 M 203.84 M 265.47 M 223.58 M 180.96 M
    Total Inventories 258.30 M 110.31 M 215.46 M 228.06 M 274.41 M
    Progress Payments & Others -63.39 M -108.39 M -13.59 M -29.57 M -47.94 M
    Prepaid Expenses
    Other Current Assets 218.73 M 139.38 M 188.59 M 141.07 M 215.37 M
    Current Assets Total 1.67 B 1.82 B 1.67 B 1.25 B 1.13 B
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 370.43 M 16.48 M 27.55 M 32.63 M 2.78 M
    Property, Plant & Equipment Net 421.32 M 257.09 M 307.04 M 302.47 M 280.73 M
    Property, Plant & Equipment Gross 609.36 M 411.30 M 468.94 M 425.75 M 374.01 M
    Accumulated Depreciation 188.04 M 154.20 M 161.90 M 123.28 M 93.28 M
    Other Assets 1.49 B 989.90 M 1.05 B 1.15 B 1.42 B
    Deferred Charges 6.25 M 9.39 M
    Tangible Other Assets 108.19 M 79.77 M 77.38 M 62.97 M 7.30 M
    Intangible Other Assets 1.38 B 910.12 M 972.54 M 1.09 B 1.41 B
    Total Assets 3.95 B 3.08 B 3.06 B 2.73 B 2.83 B
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 444.28 M 0.00 0.00 345.00 M 0.00
    Accrued Payroll
    Income Taxes Payable 10.45 M 0.00 30.50 M 22.30 M 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 411.49 M 376.60 M 510.14 M 519.62 M 596.01 M
    Current Liabilities Total 1.01 B 453.08 M 617.80 M 971.46 M 688.93 M
    Long Term Debt 963.22 M 400.00 M 400.00 M 0.00 345.00 M
    Provision for Risks & Charges 11.84 M 42.35 M
    Deferred Taxes -303.72 M -343.70 M -231.03 M -92.93 M -19.31 M
    Deferred Income 9.36 M 14.04 M 16.51 M 25.60 M 34.69 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 98.18 M 11.27 M -262.46 M 3.85 M 15.83 M
    Total Liabilities 1.78 B 572.36 M 769.37 M 760.79 M 982.44 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 2.18 B 2.51 B 2.29 B 1.97 B 1.85 B
    Common Stock 1.31 B 1.28 B 1.24 B 1.22 B 1.21 B
    Capital Surplus
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves
    Unappropriated (Free) Reserves -8.76 M
    Retained Earnings 892.30 M 1.23 B 1.04 B 754.95 M 637.12 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) -195,000.00 1.96 M 156,000.00 358,000.00 436,000.00
    Unrealized Gain (Loss) on Marketable Securities -28.09 M 0.00 -438,000.00 4.63 M 587,000.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 3.95 B 3.08 B 3.06 B 2.73 B 2.83 B
    Common Shares Outstanding 246.49 M 245.94 M 243.15 M 241.80 M 241.71 M